Parag Mallick
Co-Founder, Chief Scientist & DirectorDr. Parag Mallick, Ph.D., has been Chief Scientist and Director of Nautilus Biotechnology, Inc. since June 09, 2021. He co-founded Legacy Nautilus and served as its Chief Scientist and a Member of its Board of Directors from December 2016 to June 09, 2021. He has been a Member of Scientific Board at Oncimmune Holdings Plc since April 2, 2019. He is Co-Founder of Nautilus. Dr. Mallick served as an Advisor at OKM Capital. He serves as a Member of Scientific Advisory Board at January, Inc. He advises OKM on personalized and predictive medical technologies, including imaging, big data analytics, genetics and cancer research. Dr. Mallick served as Assistant Professor at Stanford University from 2011 to 2017 and as Associate Professor at Stanford University since 2017. Previously, he served as Adjunct Assistant Professor at the University of California, Los Angeles from 2005 to 2011 and at the University of Southern California from 2009 to 2011. He is a Member of the Canary Center for Cancer Early Detection. Dr. Mallick served as Director of Clinical Proteomics at Cedars-Sinai from 2005 to 2009. He received his BS in Computer Science and Biochemistry at Washington University in St. Louis and a Ph.D. in Chemistry and Biochemistry from the University of California, Los Angeles. Dr. Mallick completed his post-doctoral fellowship in clinical proteomics and systems biology at the Institute for Systems Biology from 2002 to 2004. Dr. Mallick's research at the Mallick Lab is focused on pioneering approaches for using big data, mathematical modeling and machine learning to discover cancer biomarkers and enable personalized and predictive medicine.
Positions
- Company NameNautilus Biotechnology, Inc.Stock CodeNAUTPositionCo-Founder, Chief Scientist & DirectorColleagues
